Mutations of the human PTEN gene

Human Mutation

Volumn 16, Issue 2, 2000, Pages 109-122

  Bonneau, Dominique ^a,c   Longy, Michel ^b  

^a UNIVERSITÉ DE POITIERS   (France)

^b INSTITUT BERGONIÉ   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Bannayan Riley Ruvalcaba syndrome; BRR; CD; Cowden disease; Germline mutations; PTEN; Somatic mutations; Tumor suppressor

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 10; CHROMOSOME DELETION; COWDEN SYNDROME; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; GENE MUTATION; GLIOBLASTOMA; HUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0033852872     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0     Document Type: Review

References (91)

1. Antonarakis SE and the Nomenclature Working Group. 1998. Recommendations for a nomenclature system for human gene mutations. Hum Mutat 11:1-3. http://www.interscience. wiley.com/jpages/1059-7794/nomenclature.html
2. Arch EM, Goodman BK, van Wesep RA, Liaw D, Clarke K, Parsons R, McKusik VA, Geraghty MT. 1997. Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. Am J Med Genet 71:489-493.
3. Beaudet AL, Tsui LC. 1993. A suggested nomenclature for designating mutations. Hum Mutat 2:245-248.
4. Boström J, Cobbers JM, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP, Reifenberger G. 1998. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res 58:29-33.
5. Butler MP, Wand SI, Chaganti RSK, Parsons R, Dalla-Favera R. 1999. Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas. Genes Chromosomes Cancer 24:322-327.
6. Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS, Sidransky D. 1997. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997-5000.
7. Celebi JT, Chen FF, Zhang H, Ping XL, Tsou HC, Peacocke M. 1999a. Identification of PTEN mutations in five families with Bannayan-Zonana syndrome. Exp Dermatol 8:134-139.
8. Celebi JT, Tsou HC, Chen FF, Zhang H, Ping XL, Lebwohl MG, Kezis J, Peacocke M. 1999b. Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTEN. J Med Genet 36:360-364.
9. Cheney IW, Johnson DE, Vaillancourt MT Avanzini J, Morimoto A, Demers GW, Wills KN, Shabram PW, Bolen JB, Tavtigian SV, Bookstein R. 1998. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res 58:2331-2334.
10. Cheney IW, Neuteboom STC, Vaillancourt MT Ramachandra M, Bookstein R. 1999. Adenovirus-mediated gene entry of MMAC1/PTEN to glioblastoma inhibits S phase entry by the recruitment of P27Kip2 and cyclin E/CDK2 complexes. Cancer Res 59:2318-2323.
11. Chi SG, Kim HJ, Park BJ, Min Hj, Park JH, Kim YW, Dong SH, Kim BH, Lee JI, Chang YW, Chang R, Kim WK, Yang MH. 1998. Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps in patients with Cowden disease. Gastroenterology 115:1084-1089.
12. Chiariello E, Roz L, Albarosa R, Magnani E, Finocchiaro G. 1998. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. Oncogene 16:541-545.
13. Dahia PLM, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C, Eng C. 1997. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 57:4710-4713.
14. Dahia PL, Aguiar RC, Alberta J, Kum JB, Caron S, Sill H, Marsh DJ, Ritz J, Freedman A, Stiles C, Eng C. 1999. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies. Hum Mol Genet 8:185-193.
15. Davies MA, Lu Y, Sano T, Fang X, Tang P, LaPushin R, Koul D, Bookstein R, Stokoe D, Yung WKA, Mills GB, Steck PA. 1998. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res 58:5285-5290.
16. Davies MP Gibbs FE, Halliwell N, Joyce KA, Roebuck MM, Rossi ML, Salisbury J, Sibson DR, Tacconi L, Walker C. 1999. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas. Br J Cancer 79:1542-1548.
17. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. 1998. PTEN is essential for embryonic development and tumour suppression. Nature Genet 19:348-355.
18. Duerr EM, Rolbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C, von Deimling A. 1998. PTEN Mutations in gliomas and glioneuronal tumors. Oncogene 16:2259-2264.
19. Eng C, Peacocke M. 1998. PTEN and inherited hamartoma-cancer syndromes. Nature Genet 19:223.
20. Fargnoli MC, Orlow SJ, Semel-Conception J, Bolognia JL. 1996. Clinicopathologic findings in the Bannayan-Riley-Ruvalcaba syndrome. Arch Dermatol 132:1214-1218.
21. Feilotter HE, Nagai MA, Boag AH, Eng C, Mulligan LM. 1998. Analysis of PTEN and the 10q23 region in primary prostate carcinomas. Oncogene 16:1743-1748.
22. Freihoff D, Kempe A, Beste B, Wappenschmidt B, Kreyer E, Hayashi Y, Mendl A, Krebs D, Wiestler OD, von Deimling A, Schmutzler RK. 1999. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas. Br J Cancer 79:754-758.
23. Fults D, Pedone CA, Thompson GE, Uchiyama CM, Gumpper K, Iliev D, Vinson VL, Tavtigian SV, Perry WL. 1998. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MX11 in human glioblastoma multiforme. Int J Oncol 12:905-910.
24. Furnari FB, Lin H, Su Huang HJ, Cavenee WB. 1997. Growrh suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci 94:12479-12484.
25. Furnari FB, Su Huang HJ, Cavenee WB. 1998. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res 58:5002-5008.
26. Gray IC, Stewart LM, Phillips SM, Hamilton JA, Gray NE, Watson GJ, Spurr NK, Snary D. 1998. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN. Br J Cancer 78:1296-300.
27. Grønbæk K, Zeuthen J, Guldberg P, Ralfkiaer E, Hou-Jensen K. 1998. Alterations of the MMAC1/PTEN gene in lymphoid malignancies. Blood 91:4388-4390.
28. Guldberg P, Straten PT, Birck A, Ahrenkiel V, Kirkin AF, Zeuthen J. 1997. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57:3660-3663.
29. Gurin CC, Federici MG, Kang L, Boyd J. 1999. Causes and consequences of microsatellite instability in endometrial carcinoma. Cancer Res 59:462-466.
30. Halachmi N, Halachmi S, Evron E, Cairns P, Okami K, Saji M, Westra WH, Zeiger MA, Jen J, Sidransky. 1998. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer 23:239-243.
31. Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P, Tomlinson IPM, Houlston RS, Bevan S, Mitros FA, Stone EM, Aaltonen LA. 1998. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280:1086-1088.
32. Iida S, Nakamura Y, Fujii H, Kimura M, Moriwaki K. 1998a. A heterozygous germline mutation of the PTEN/MMAC1 gene in a patient with Cowden disease. Int J Mol Med 1:565-568.
33. Iida S, Tanaka Y, Fujii H, Hayashi S, Kimura M, Nagareda T, Moriwaki K. 1998b. A heterozygous frameshift mutation of the PTEN/MMAC1 gene in a patient with Lhermitte-Duclos disease - only the mutated allele was expressed in the cerebellar tumor. Int J Mol Med 1:925-929.
34. Kohno T, Takahashi M, Fukutomi T, Ushio K, Yokota J. 1998a. Germline mutations of the PTEN/MMAC1 gene in Japanese patients with Cowden Disease. Jpn J Cancer Res 89:471-474.
35. Kohno T, Takahashi M, Manda R, Yokota J. 1998b. Inactivation of the PTEN/ MMAC1/TEP1 gene in human lung cancers. Genes Chromosomes Cancer 22:152-156.
36. Kong D, Suzuki A, Zou TT, Sakurada A, Kemp LW Wakatsuki S, Yokoyama T, Yamakawa H, Furukawa T, Sato M, Ohuchi N, Sato S, Yin J, Wang S, Abraham JM, Souza RF, Smolinski KN, Meltzer SJ, Horii A. 1997. PTEN1 is frequently mutated in primary endometrial carcinomas. Nature Genet 17:143-144.
37. Kurose K, Bando K, Fukino K, Sugisaki Y, Araki T, Emi M. 1998. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles. Jpn J Cancer Res 89:842-848.
38. Kurose K, Araki T, Matsunaka T, Takada Y, Emi M. 1999. Variant manifestation of Cowden disease in Japan: hamartomatous polyposis of the digestive tract with mutation of the PTEN gene. Am J Med Genet 64:308-310.
39. Levine RL, Cargile CB, Blazes MS, van Rees B, Kurman RJ, Ellenson LH. 1998. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 58:3524-3528.
40. Li DM, Sun H. 1997. TEP1, encoded by a candidate tumor-suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor. Cancer Res 57: 2124-2129.
41. Li DM, Sun H. 1998. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cycle arrest in human glioblastoma cells. Proc Nad Acad Sci USA 95:15406-15411.
42. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in humain brain, breast, and prostate cancer. Science 275:1943-1947.
43. Li J, Simpson L, Takahasi M, Miliaresis C, Myers MP, Tonks N, Parsons R. 1998. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res 58:5667-5672.
44. Liaw D, Marsh D, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R. 1997. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet 16:64-67.
45. Lin WM, Forgacs E, Warshal DR Yeh IT, Martin JS, Ashfaq R, Muller CY. 1998. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin Cancer Res 4:2577-2583.
46. Liu W, James CD, Frederick L, Alderete BE, Jenkins RB. 1997. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 57:5254-5257.
47. Longy M, Coulon V, Duboué B, David A, Larrègue M, Eng C, Amati P, Kraimps JL, Bottani A, Lacombe D, Bonneau D. 1998. Mutations of PTEN in Patients with Bannayan-Riley-Ruvalcaba Phenotype. J Med Genet 35:886-889.
48. Lynch ED, Ostermeyer EA, Lee MK, Arena F, Ji HL, Dann J, Swisshelm K, Suchard D, McLeod PM, Kvinnsland S, Gjertsen BT, Heimdal K, Lubs H, Moller P, King MC. 1997. Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. Am J Hum Genet 61:1254-1260.
49. Maehama T, Dixon JE. 1998. The tumor suppressor, PTEN/ MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J Biol Chem 273:13375-13378.
50. Marsh DJ, Dahia PLM, Zheng Z, Liaw D, Parsons R, Gorlin RJ, Eng C. 1997. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nature Genet 16:333-334.
51. Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PLM, Zheng Z, Liaw D, Caron S, Duboué B, Lin AY, Richardson AL, Bonnetblanc JM, Bressieux JM, Cabarrot-Moreau A, Chompret A, Demange L, Eeles RA, Yahanda AM, Fearon ER, Fricker JP, Gorlin RJ, Hodgson SV, Huson S, Lacombe D, Leprat F, Odent S, Toulouse C, Olopade OI, Sobol H, Tishler S, Woods CG, Robinson BG, Weber HC, Parsons R, Peacocke M, Longy M, Eng C. 1998a. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 7:507-515.
52. Marsh DJ, Dahia PLM, Caron S, Kum JB, Frayling IM, Tomlinson IPM, Hughes KS, Eeles RA, Hodgson SV, Murday VA, Houlston R, Eng C. 1998b. Germline PTEN mutations in Cowden syndrome-like families. J Med Genet 35:881-885.
53. Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, Bodurtha J, Crowe C, Curtis MA, Dasouki M, Dunn T, Feit H, Geraghty MT Graham Jr JM, Hodgson SV, Hunter A, Korf BR, Manchester D, Miesfeldt S, Murday VA, Nathanson KL, Parisi M, Pober B, Romano C, Tolmie JL, Trembath, Winter RM, Zackai EH, Zori RT, Weng LP, Dahia PLM, Eng C. 1999. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 8:1461-1472.
54. Maxwell GL, Risinger JI, Gumbs C, Shaw H, Bentley RC, Barrett JC, Berchuck A, Futreal PA. 1998. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res 58:2500-2503.
55. Minaguchi T, Mori T, Kanamori Y, Matsushima M, Yoshikawa H, Takenati Y, Nakamura Y. 1999. Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene. Cancer Res 59:6063-6067.
56. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK. 1997. P-TEN the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Nad Acad Sci 94:9052-9057.
57. Myers MP, Pass I, Batty IH, van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK. 1998. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci 95:13513-13518.
58. Nakahara Y, Nagai H, Kinoshita T, Uchida T, Hatano S, Mutate T, Saito H. 1998. Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma. Leukemia 12:1277-1280.
59. Nelen MR, Padberg GW, Peeters EAJ, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MMM, Easton DF, Eeles RA, Hodgson S, Mulvihill JJ, Murday VA, Tucker MA, Mariman ECM, Starink TM, Ponder BAJ, Ropers HH, Kremer H, Longy M, Eng C. 1996. Localization of the gene for Cowden disease to chromosome 10q22-23. Nature Genet 13:114-116.
60. Nelen MR, van Starveren WCG, Peeters EAJ, Ben Hassel M, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH, Woods DG, Mariman ECM, Padberg GW, Kremer H. 1997. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 6:1383-1387.
61. Nelen M, Kremer H, Konings H, Schoute F, van Essen AJ, Koch R, Woods DG, Fryns JP, Hoefsloot L, Peeters E, Padberg G. 1999. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype - phenotype correlations. Eur J Hum Genet 7:267-273.
62. Obata K, Morland SJ, Watson RH, Hitchcock A, Chevenix-Trench G, Thomas EJ, Campbell IG. 1998. Frequent PTEN/ MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res 58:2095-2097.
63. Okami K, Wu L, Riggins G, Cairns P, Goggins M, Evron E, Halachmi N, Ahrendt SA, Reed AL, Hilgers W, Kern SE, Koch WM, Sidransky D, Jen J. 1998. Analysis of PTEN/ MMAC1 alterations in aerodigestive tract tumors. Cancer Res 58:509-511.
64. Olschwang S, Sereva-Sinilnikova OM, Lenoir G, Thomas G. 1998. PTEN germline mutations in juvenile polyposis coli. Nature Genet 18:12-14.
65. Peraud A, Watanabe K, Schwechheimer K, Yonekawa Y, Kleihues P, Ohgaki H. 1999. Genetic profile of the giant cell glioblastoma. Lab Invest 79:123-129.
66. Pesche S, Latil A, Muzeau F, Cussenot O, Fournier G, Longy M, Eng C, Lidereau R. 1998. PTEN/MMAC1/TEP1 involvement in primary prostate cancers. Oncogene 16:2879-2883.
67. Raizis AM, Ferguson MM, Robinson BA, Atkinson CH, George PM. 1998. Identification of a novel PTEN mutation (L139X) in a patient with Cowden disease and Sjögren's syndrome. Mol Pathol 51:339-341.
68. Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR. 1999. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 96:2110-2115.
69. Rasheed BKA, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH. 1997. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57:4187-4190.
70. Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI, Boyd J. 1997. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 57:3657-3659.
71. Risinger JI, Hayes AK, Berchuck A, Barrett JC. 1997. PTEN/ MMAC1 mutations in endometrial cancers. Cancer Res 57:4736-4738.
72. Risinger JI, Hayes K, Maxwell GL, Carney ME, Dodge RK, Barrett JC, Berchuck A. 1998. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res 4:3005-3010.
73. Sakai A, Thieblemont C, Wellmann A, Jaffe ES, Raffeld M. 1998. PTEN gene alterations in lymphoid neoplasms. Blood 92:3410-3415.
74. Scala S, Bruni P, Lo Muzio L, Mignogna M, Viglieto G, Fusco A. 1998. Novel mutation of the PTEN gene in an italian Cowden's disease kindred. Int J Oncol 13:665-668.
75. Simpkins SB, Peiffer-Schneider S, Mutch DG, Gersell D, Goodfellow PJ. 1998. PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors. Gynecol Oncol 71:391-395.
76. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 15:356-362.
77. Sutphen R, Diamond TM, Minton SE, Peacocke M, Tsou HC, Root AW. 1999. Severe Lhermitte-Duclos disease with unique germline mutation of PTEN. Am J Med Genet 82:290-293.
78. Suzuki H, Freije D, Nusskern DR, Okami K, Carins P, Sidransky D, Isaaacs WB, Bova S. 1998. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 58:204-209.
79. Tamura M, Gu J, Matsumoto K, Aota SI, Parsons R, Yamada KM. 1998. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614-1617.
80. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R, Ellenson LH. 1997. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57:3935-3940.
81. Teng DHF, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Lansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LE, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung TWK, Fujii G, Berson A, Bookstein R, Bolen JB, Tavtigian SV, Steck PA. 1997. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57:5221-5225.
82. Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y, Kleihues P, Ohgaki H. 1998. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 57:684-689.
83. Tsou HC, Teng DHF, Ping XL, Brancolini V, Davis T, Hu R, Xie XX, Gruener AC, Schrager CA, Christiano AM, Eng C, Steck P, Ott J, Tavtigian SV, Peacocke M. 1997. The role of MMAC1 mutations in early-onset breast: causative in association with Cowden syndrome and excluded in BRCA1-negative cases. Am J Hum Genet 61:1036-1043.
84. Tsou HC, Ping XL, Xie XX, Gruener AC, Zhang H, Nini R, Swisshelm K, Sybert V, Diamond TM, Sutphen R, Peacocke M. 1998. The genetic basis of Cowden's syndrome: three novel mutations in PTEN/MMAC1/TEP1. Hum Genet 102: 467-473.
85. Tsuchiya KD, Wiesner G, Cassidy SB, Limwongse C, Boyle JT, Schwartz S. 1998. Deletion 10q23.2-q23.33 in a patient with gastrointestinal juvenile polyposis and other features of a Cowden-like syndrome. Genes Chromosomes Cancer 21:113-118.
86. Ueda K Nishijima M, Inui H, Watatani M, Yayoi E, Okamura J, Yasutomi M, Nakamura Y, Miyoshi Y. 1998. Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers. Jpn J Cancer Res 89:17-21.
87. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R. 1997. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57:4183-4186.
88. Weng LP, Smith WM, Dahia PLM, Ziebold U, Gil E, Lees JA, Eng C. 1999. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Cancer Res 59:5808-5814.
89. Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL. 1998. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci 95:15587-15591.
90. Zhou XP, Li YJ, Hoang-Xuan K, Puig PL, Mokhtari K, Longy M, Sanson M, Delattre JY, Thomas G, Hamelin R. 1999. Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations. Int J Cancer 84:150-154.
91. Zori RT, Marsh DJ, Graham GE, Marliss EB, Eng C. 1998. Germline PTEN mutation in family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 80:399-402.